top of page

MENU

  • AutorenbildJuergen Mairhofer

enGenes to share continuous growth-decoupled production insights at World Biopharm 2023

Vienna, Austria: – Recombinant proteins specialist CDMO enGenes Biotech GmbH (enGenes) will be a prominent presence as a scientific contributor to the upcoming World Biopharm Forum in Oxford, England.

The enGenes presentation to the conference will detail the recent progress it has made as part of the ECOnti consortium towards continuous biomolecule production in E. coli for reduced footprint microbial manufacturing.

Biopharma manufacturing innovation

The Austrian Government-funded ECOnti project is seeking to develop an accelerated, low ecological footprint, manufacturing platform for continuous production of biotechnological products that features a fully integrated and automated continuous upstream and downstream process at up to 10 L batch size.

This project goals closely align with the 2023 World Biopharm Forum theme of ‘Democratization of Biotherapies: New Manufacturing Modalities & Intensifications’.

Comments


bottom of page